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meningococcal disease conditional on carriage (q) to US inci-
dence data. Calibration used the maximum likelihood method;
goodness-of-ﬁt was assessed using deviance. RESULTS: The cal-
culated b for infant-to-infant transmission is 1.86 effective con-
tacts per 100,000 infants per year. b peaks at 29.7/100,000 for
transmission between 14 year olds and 11–14 year olds, and
ranges from 0 to 16.3/100,000 for adult-adult transmission. The
q is highest in infants (0.015), declines steeply and plateaus at
0.00013 in those aged >20 years. The model predicted yearly
cases of ACWY-related meningococcal disease are 132 among
infants, 439 among 1–20 year-olds, and 202 among those aged
>20, compared with 129, 433, and 211 for US benchmarks
(deviance = 184, with 72 degrees of freedom). CONCLUSIONS:
Calibration techniques can be used to adapt a UK meningococcal
disease model to the US using modiﬁed serogroup and contact
data such that a reasonable ﬁt is achieved with US benchmarks.
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OBJECTIVES: To determine the relation with active smoking
patients in presence of asthma and COPD, and to know its
association with some cardiovascular risk factors and its cost
repercussion of attended patients in a Spanish population setting.
METHODS: Multi-centric retrospective design realised begin-
ning from subjects older than 14 years demanding assistance
during year 2006. Smoking habit, asthma and COPD were
deﬁned as a clinical illness obtained according to International
Classiﬁcation CIAP-2. Main measures: age, gender, co-
morbidities (cardiovascular), Charlson index (patient severity)
and costs model (ﬁxed/semi-ﬁxed: in operation) and variable
ones (diagnostics/therapeutics tests and referrals). Statistic analy-
sis: logistics regression and covariance (ANCOVA) for the
correction of the model (recommendations: Thompson-Barber).
Program SPSSWIN, p < 0.05. RESULTS: A total of 65,768
patients (use: 73.1%; frequentation: 4.7 visits/100 inhabitants).
The 4.1% (n = 2,693, conﬁdence intervals of the 95% [CI]:
3.9–4.3%) presented asthma and the 2.7% (n = 1,769, CI: 2.6–
2.8%) COPD. The percentage of active smokers was 20.2% (CI:
18.7–21.7%) and 27.0% (CI: 24.9–29.1%), p = NS, respectively.
In general, asthmatic patients were associated to feminine gender
(OR = 1.7) and in younger ages (15–44 years: 52.2%),
p < 0.001; while COPD to masculine gender (women: OR = 0.2),
older ages (65–74 years: 64.5%) and cardiovascular events (OR:
1.2). In both patients of high co-morbidity and with obesity
(OR = 1.5 and OR = 1.4; in asthma and COPD respectively).
The average of adjusted total cost/unitary was superior in COPD
(€1,146.30) especially in pharmaceutical cost. CONCLUSIONS:
The existence of active smoking patients in presence of asthma
and COPD is high. In primary prevention should be established
measures to carry out the reduction of cardiovascular risk factors
(smoking and obesity), above all in subjects with COPD, were
the resources consume and risks are higher.
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OBJECTIVES: To investigate the relative effectiveness of inhaled
cortcosteroids (ICS) and leukotriene-receptor anragonists to
prevent moderat-to-severe exacerbations among asthmatic chil-
dren. METHODS: From the linkage of two administrative health
databases from Quebec, Canada, we reconstructed a cohort of
asthmatic children aged 5 to 15 years that initiated a treatment
with either ICS or LTRA between January ﬁrst 1998 and August
31, 2005. Patients were followed between 4 and 12 months. The
primary outcome was moderate-to-severe asthma exacerbations
deﬁned as an emergency department (ED) visit for asthma, a
hospitalization for asthma or a dispensed short-course (14
days) prescription of oral corticosteroids. Patients’ adherence to
their controller therapy was estimated with the medication pos-
session ratio (MPR). All analyses were stratiﬁed by the presence
or not of an asthma exacerbation in the year before treatment
initiation with ICS or LTRA. We estimated the adjusted rate
ratios of moderate-to-severe asthma exacerbations comparing
patients treated with ICS and LTRA with Poisson regression
models including a dispersion parameter. The mean MPR was
compared between ICS and LTRA users with a t-test. RESULTS:
A total of 27,355 children were included in the cohort: 7,494
(27%) with and 19,861 (73%) without an exacerbation in the
year prior to treatment initiation. Among children with no exac-
erbation before treatment initiation, the risk of exacerbations
was signiﬁcantly more than twice with ICS versus LTRA
(adjusted RR = 2.3; 95% CI; 1.3–4.0), while the RR was not
signiﬁcant among children who had at least 1 exacerbation
before treatment initiation (adjusted RR = 1.6; 95% CI: 0.8–
3.1). The mean MPR was 0.16 for ICS compared to 0.35 for
LTRA, among children with at least 1 exacerbation prior to
treatment initiation (p < 0.001). These means were 0.15 and
0.30, respectively, among children with no previous exacerbation
(p < 0.001). CONCLUSIONS: Among children free of exacerba-
tions prior to treatment initiation, our study showed that ICS
users were more than twice more likely to have an exacerbation
than LTRA users and that higher adherence to LTRA may have
accounted for this result.
PRS3
PREVALENCE OF CHRONIC OBSTRUCTIVE
PULMONARY DISEASE FROM ADMINISTRATIVE
HEATH SERVICES DATABASES
Citarella A, Menditto E, Cammarota S, De Portu S, Riegler S,
Mantovani LG
University of Naples, Federico II, Naples, Italy
OBJECTIVES: To identify subjects affected by Chronic Obstruc-
tive Pulmonary Disease (COPD) in a local health authority of
approximately 441 thousand inhabitants situated in Campania,
a region in the southwest of Italy. METHODS: A retrospective
naturalistic longitudinal study was conducted using record
linkage between administrative health services databases (drug
prescription, hospital admissions, demographic). We enrolled
subjects with greater than or equal to 45 years old who had
during the period 2006/2007 an hospital admission for Chronic
Bronchitis (ICD-9 cod.491) and/or received drugs chronic pre-
scription for obstructive diseases from the R03 Anatomical
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